Zoonotic Influenza Infections of Swine Origin at Ohio Agricultural Fairs
NCT ID: NCT02124096
Last Updated: 2019-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
336 participants
OBSERVATIONAL
2014-04-25
2019-06-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
\- The flu is a very infectious and contagious virus that affects both people and pigs. Studies show that pigs can be sources of the flu virus in humans. Researchers want to know more about how the flu is transmitted from animals to people. If they know more about it, they can find better ways to prevent the flu and treat people who get sick from it.
Objective:
\- To discover if flu viruses can be found in people exposed to pigs at Ohio agricultural fairs.
Eligibility:
\- Volunteers 8 years of age and older who exhibit pigs at Ohio agricultural fairs.
Design:
* Before or on the first day of the fair, participants will fill out a short demographic and medical history form. They will also complete a two-page symptom questionnaire. This is a form that asks them about any flu symptoms they might have.
* Participants will have a nasal swab performed. The inside of the participant s nose will be rubbed with a swab to collect nasal fluid.
* Researchers will see participants 2 days later and 4 days later. During these visits, participants will again fill out a symptom questionnaire and have a nasal swab.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Household Transmission of Zoonotic Influenza Viruses in a Cohort of Egyptian Poultry Growers
NCT02459171
A Pilot Study for Collection of Anti-Influenza A Immune Plasma
NCT00984451
Blood and Plasma Collection For Use in Future Clinical Trials
NCT01136057
Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
NCT05027932
A/H5N1 Vaccine in Healthy Children Aged 2-9 Years
NCT00133536
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In 2009, a pandemic occurred with the emergence of the H1N1 pandemic (pdm) virus which was found to have originated from both a North American and European swine lineage, again reinforcing how viruses evolving in swine can lead to important human pathogens. Interestingly this virus was transmitted back into swine and birds in North America. In 2011, an H3N2 swine origin influenza virus known as the H3N2v and containing the H1N1pdm matrix genomic segment was reported causing human infections in multiple parts of the US. In 2012, these cases increased, especially during the summer months. Since 2011, 321 confirmed cases have been reported from 13 states including 107 cases in Ohio. Almost all of these cases have been linked to swine exposure on farms or at agricultural fairs.
Study of these zoonotic transmission events at agricultural fairs are necessary in order to better understand how and why these events occur, how human pathogens emerge, and how to potentially prevent events from occurring. These events could lead to new pandemics and epidemics so their prevention is crucial. The goal of this study is to examine rates of bidirectional zoonotic transmission at Ohio agricultural fairs. Through collection of viruses and host samples, we hope to begin to answer questions regarding how viruses cross species barriers, adapt to new hosts, and how these events could impact overall influenza virus evolution.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Parental consent if a participant is less than 18 years of age
* Willing to have samples stored for future research
* Willingness to complete all study procedures
* Daily or nearly daily contact with swine during selected agricultural fairs
Exclusion Criteria
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ohio State University
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew J Memoli, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ohio State University, College of Veterinary Medicine
Columbus, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Webster RG. The importance of animal influenza for human disease. Vaccine. 2002 May 15;20 Suppl 2:S16-20. doi: 10.1016/s0264-410x(02)00123-8.
Reid AH, Taubenberger JK. The origin of the 1918 pandemic influenza virus: a continuing enigma. J Gen Virol. 2003 Sep;84(Pt 9):2285-2292. doi: 10.1099/vir.0.19302-0.
Gray GC, McCarthy T, Capuano AW, Setterquist SF, Olsen CW, Alavanja MC. Swine workers and swine influenza virus infections. Emerg Infect Dis. 2007 Dec;13(12):1871-8. doi: 10.3201/eid1312.061323.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-I-N092
Identifier Type: -
Identifier Source: secondary_id
999914092
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.